Association CYP3A5 gene polymorphisms with tacrolimus blood concentration in heart transplant recipients

被引：0
|
作者：
Gichkun, Olga [1 ]
Shevchenko, Olga [1 ]
Koloskova, Nadegda [1 ]
Shmerko, Natalia [1 ]
Ilchuk, Maria [1 ]
Shevchenko, Alex [1 ]
机构：
[1] Shumakov Natl Med Res Ctr Transplantol & Artifici, Moscow, Russia
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.040
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [31] Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients
    Gijsen, Violette
    Mital, Seema
    van Schaik, Ron H.
    Soldin, Offie P.
    Soldin, Steven J.
    van der Heiden, Ilse P.
    Nulman, Irena
    Koren, Gideon
    de Wildt, Saskia N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12): : 1352 - 1359
  • [32] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [33] CYP3A5*3 and POR*28 Genetic Variants Influence the Required Dose of Tacrolimus in Heart Transplant Recipients
    Lesche, Dorothea
    Sigurdardottir, Vilborg
    Setoud, Raschid
    Oberhaensli, Markus
    Carrel, Thierry
    Fiedler, Georg M.
    Largiader, Carlo R.
    Mohacsi, Paul
    Sistonen, Johanna
    THERAPEUTIC DRUG MONITORING, 2014, 36 (06) : 710 - 715
  • [34] CYP3A5 gene mutation and effect on tacrolimus blood level
    Yasri, Sora
    Wiwanitkit, Viroj
    IMMUNOPATHOLOGIA PERSA, 2018, 4 (01):
  • [35] CYP3A5 Polymorphisms Leading to Tacrolimus Toxicity Following an Adult Renal Transplant
    Alotaibi, Nouf
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (03) : 250 - 253
  • [36] The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients
    Zhang, Jing-Jing
    Liu, Shuai-Bing
    Xue, Ling
    Ding, Xiao-Liang
    Zhang, Hua
    Miao, Li-Yan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (09) : 728 - 736
  • [37] ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT
    Alghamdi, A.
    Lazear, D.
    Varnell, C.
    Seay, S.
    Hooper, D.
    Darland, L.
    Mizuno, T.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S10 - S10
  • [38] Influence of donor CYP3A5 gene polymorphism on tacrolimus dose requirement in pediatric liver transplant recipients
    Ayme, E.
    Debray, D.
    Durand, P.
    Fabre, M.
    Furlan, V.
    Bouligand, J.
    Kolaci, M.
    Verstuyft, C.
    Becquemont, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 75 - 75
  • [39] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [40] Association of Hemoglobin Levels, CYP3A5, and NR1I3 Gene Polymorphisms with Tacrolimus Pharmacokinetics in Liver Transplant Patients
    Chen, Dawei
    Guo, Feng
    Shi, Jinxiu
    Zhang, Chenhui
    Wang, Zhaowen
    Fan, Junwei
    Peng, Zhihai
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (03) : 249 - 253
12345